Pharmacogenomics Testing, Behavioral Health for Medicare
Customize your policy alerts
Sign up for Presbyterian Health Plan Policy 30.0 alerts
Get alerted when Policy 30.0 changes without checking for updates manually.
Monitor payer policy activity
This policy governs limited coverage and prior authorization for pharmacogenomics testing, including single-gene tests, multigene panels, and combinatorial tests. Medicare coverage follows specified contractor guidance; testing is non-covered and investigational for Medicaid and Commercial members.
Medicare coverage now follows Novitas pharmacogenomics LCD L39063 and related article A58801, with LCD L38435 and related article A58395 also identified as applicable guidance.
Multiple molecular pathology and proprietary pharmacogenomics codes were added or updated, including codes requiring prior authorization.
IDgenetix code 0411U was designated investigational and non-covered for non-Medicare products while remaining subject to case-by-case Medicare review.
GeneSight Psychotropic code 0345U was designated investigational and non-covered for Medicare, Medicaid, and Commercial products.
Deleted code 0033U was removed from the policy effective January 1, 2026.
Codes 0173U and 0175U were returned from the Laboratory Benefit Management policy and require prior authorization for all lines of business.
Codes 0411U and 0345U remain configured as investigational and experimental for all lines of business.
The policy continues Medicare-only coverage and requires prior authorization for listed pharmacogenomic codes except for specified no-prior-authorization codes.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.